Investors & Media Stock information Stock is Data Provided by Refinitiv. Minimum 15 minutes delayed. Press releases May 2, 2024 Dyne Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Recent Business Highlights read more March 27, 2024 Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer read more view all Events No events scheduled view all Corporate presentation Corporate Presentation - May 2024 Corporate Presentation - May 2024 4.3 MB